Thrombocytosis and Thrombocytopenia in Treatment-Naïve Rheumatoid Arthritis Patients: A Single-Centre Retrospective Data-Based Study From Pakistan

Background and objective This study aims to investigate thrombocytosis and thrombocytopenia in treatment-naïve rheumatoid arthritis (RA) patients, addressing the lack of data on their prevalence and clinical significance. By focusing on untreated patients, this study seeks to clarify the disease...

Full description

Saved in:
Bibliographic Details
Published inCurēus (Palo Alto, CA) Vol. 16; no. 11; p. e73112
Main Authors Butt, Nauman Ismat, Ghoauri, Muhammad Sohail Ajmal, Waris, Barak, Javed, Muhammad Umair, Sabeh, Dure, Qaisar, Fahad
Format Journal Article
LanguageEnglish
Published United States 06.11.2024
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Background and objective This study aims to investigate thrombocytosis and thrombocytopenia in treatment-naïve rheumatoid arthritis (RA) patients, addressing the lack of data on their prevalence and clinical significance. By focusing on untreated patients, this study seeks to clarify the disease's natural course without confounding factors from prior therapies. The research is particularly important in the Pakistani context, where regional variations in RA presentation are underexplored. Findings are expected to enhance understanding of these hematological changes, ultimately guiding improved clinical management strategies for RA. Methods The present retrospective data-based study was conducted at the Department of Medicine & Allied Health Sciences, Azra Naheed Medical College, Superior University, Lahore, Pakistan. The 2010 American College of Rheumatology (ACR) diagnostic criteria were used to define RA. Thrombocytosis was defined as a platelet count greater than 400×10 /L. Thrombocytopenia was defined as a platelet count less than 150×10 /L. The Disease Activity Score in 28 joints (DAS-28 score) was used to categorize the disease severity of RA. Retrospective data were collected from the medical records of 165 patients with RA. Records from January 2023 to December 2023 were included. The assessment included demographic information, rheumatoid factor status, anti-CCP antibody status, disease severity measured by the DAS-28 score, and complete blood count (CBC) results, such as hemoglobin, white blood cell (WBC) count, and platelet count. Data entry and analysis were conducted using IBM SPSS Statistics software, version 23 (IBM Corp., Armonk, NY). Results The mean age of the patients was 42.5±13.6 years, with 25 (15.2%) male and 140 (84.8%) female patients. The RA factor (RAF) was positive in 128 (77.6%) and the anti-CCP antibody in 102 (61.8%). The mean DAS-28 score was 4.5±1.4, with 113 (68.5%) patients having mild-to-moderate disease and 52 (31.5%) patients having severe disease. Mean hemoglobin, WBC, and platelet counts were 12.0±1.4 g/dl, 9.0±2.7 ×10 /L, and 352.6±110.4 ×10 /L, respectively. Thrombocytosis was seen in 52 (31.5%) patients, while thrombocytopenia was seen in 11 (6.7%). Conclusion Thrombocytosis was seen in almost one-third of RA patients, having a significant association with age, the RAF factor positivity, and anti-CCP antibody negativity but not with gender and disease severity. Thrombocytopenia was relatively uncommon.
AbstractList Background and objective This study aims to investigate thrombocytosis and thrombocytopenia in treatment-naïve rheumatoid arthritis (RA) patients, addressing the lack of data on their prevalence and clinical significance. By focusing on untreated patients, this study seeks to clarify the disease's natural course without confounding factors from prior therapies. The research is particularly important in the Pakistani context, where regional variations in RA presentation are underexplored. Findings are expected to enhance understanding of these hematological changes, ultimately guiding improved clinical management strategies for RA. Methods The present retrospective data-based study was conducted at the Department of Medicine & Allied Health Sciences, Azra Naheed Medical College, Superior University, Lahore, Pakistan. The 2010 American College of Rheumatology (ACR) diagnostic criteria were used to define RA. Thrombocytosis was defined as a platelet count greater than 400×10 /L. Thrombocytopenia was defined as a platelet count less than 150×10 /L. The Disease Activity Score in 28 joints (DAS-28 score) was used to categorize the disease severity of RA. Retrospective data were collected from the medical records of 165 patients with RA. Records from January 2023 to December 2023 were included. The assessment included demographic information, rheumatoid factor status, anti-CCP antibody status, disease severity measured by the DAS-28 score, and complete blood count (CBC) results, such as hemoglobin, white blood cell (WBC) count, and platelet count. Data entry and analysis were conducted using IBM SPSS Statistics software, version 23 (IBM Corp., Armonk, NY). Results The mean age of the patients was 42.5±13.6 years, with 25 (15.2%) male and 140 (84.8%) female patients. The RA factor (RAF) was positive in 128 (77.6%) and the anti-CCP antibody in 102 (61.8%). The mean DAS-28 score was 4.5±1.4, with 113 (68.5%) patients having mild-to-moderate disease and 52 (31.5%) patients having severe disease. Mean hemoglobin, WBC, and platelet counts were 12.0±1.4 g/dl, 9.0±2.7 ×10 /L, and 352.6±110.4 ×10 /L, respectively. Thrombocytosis was seen in 52 (31.5%) patients, while thrombocytopenia was seen in 11 (6.7%). Conclusion Thrombocytosis was seen in almost one-third of RA patients, having a significant association with age, the RAF factor positivity, and anti-CCP antibody negativity but not with gender and disease severity. Thrombocytopenia was relatively uncommon.
Author Qaisar, Fahad
Butt, Nauman Ismat
Javed, Muhammad Umair
Sabeh, Dure
Waris, Barak
Ghoauri, Muhammad Sohail Ajmal
Author_xml – sequence: 1
  givenname: Nauman Ismat
  surname: Butt
  fullname: Butt, Nauman Ismat
  organization: Internal Medicine/Rheumatology, Azra Naheed Medical College, Superior University, Lahore, PAK
– sequence: 2
  givenname: Muhammad Sohail Ajmal
  surname: Ghoauri
  fullname: Ghoauri, Muhammad Sohail Ajmal
  organization: Neurology, Bahawal Victoria Hospital, Quaid-e-Azam Medical College, Bahawalpur, PAK
– sequence: 3
  givenname: Barak
  surname: Waris
  fullname: Waris, Barak
  organization: Medicine and Allied Health Sciences, Azra Naheed Medical College, Superior University, Lahore, PAK
– sequence: 4
  givenname: Muhammad Umair
  surname: Javed
  fullname: Javed, Muhammad Umair
  organization: Medicine, Bahawal Victoria Hospital, Quaid-e-Azam Medical College, Bahawalpur, PAK
– sequence: 5
  givenname: Dure
  surname: Sabeh
  fullname: Sabeh, Dure
  organization: Medicine, Bahawal Victoria Hospital, Quaid-e-Azam Medical College, Bahawalpur, PAK
– sequence: 6
  givenname: Fahad
  surname: Qaisar
  fullname: Qaisar, Fahad
  organization: Medicine, Bahawal Victoria Hospital, Quaid-e-Azam Medical College, Bahawalpur, PAK
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39650908$$D View this record in MEDLINE/PubMed
BookMark eNpNkEFOwzAQRS1UREvpjjXyAUixHSe22ZVCAQkBotlHTjKlhiapbAep5-AgHIKLYSigrjwevT8zeoeo17QNIHRMyViIRJ2VnYXOjUVMKdtDA0ZTGUkqeW-n7qORcy-EEEoEI4IcoH6s0oQoIgfoPVvati7acuNbZxzWTYV3WmtojMamwZkF7WtofHSvPz_eAD8toau1b02FJ9YvrfEh_ai9CYw7xxM8N83zCqJp-NuAg7etW0PpTQhfaq-jC-2gwnPfVRs8CxtD-tU4r5sjtL_QKwej33eIstlVNr2J7h6ub6eTu6hMiYxUAoJLACgUcF2KJI2FKPmiYIyJIua8SAhjqaIcRJJwyZmSlElRkUqxAlQ8RKfbsWW4zFlY5Gtram03OSX5t918azf_sRvwky2-7ooaqn_4z2X8BeZ3e1s
Cites_doi 10.1097/MD.0000000000019096
10.1136/ard.35.2.138
10.1093/rheumatology/kez343
10.1158/1535-7163.MCT-22-0323
10.3389/fimmu.2018.00880
10.1080/030097402760375124
10.12669/pjms.344.15281
10.1016/S2665-9913(23)00211-4
10.1186/s40360-024-00738-6
10.1016/j.berh.2007.05.007
10.3109/s101650170013
10.1007/s00296-010-1747-0
10.1093/rheumatology/kel204
10.1016/j.hoc.2013.03.001
10.1186/ar1886
10.33545/pathol.2019.v2.i2g.134
10.1185/030079908x261177
10.1016/j.jaut.2012.12.009
10.1093/rheumatology/kes279
10.3390/life12010077
10.1186/1750-1172-2-3
10.1093/rheumatology/38.7.668
10.69656/pjp.v19i4.1537
10.4103/0256-4947.51774
10.4103/0019-5049.144643
ContentType Journal Article
Copyright Copyright © 2024, Butt et al.
Copyright_xml – notice: Copyright © 2024, Butt et al.
DBID NPM
AAYXX
CITATION
DOI 10.7759/cureus.73112
DatabaseName PubMed
CrossRef
DatabaseTitle PubMed
CrossRef
DatabaseTitleList PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2168-8184
ExternalDocumentID 10_7759_cureus_73112
39650908
Genre Journal Article
GroupedDBID 3V.
53G
5VS
7X7
8FI
8FJ
ABUWG
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
FYUFA
GROUPED_DOAJ
HMCUK
HYE
KQ8
M48
NPM
OK1
PGMZT
PIMPY
PQQKQ
PROAC
RPM
UKHRP
AAYXX
CITATION
ID FETCH-LOGICAL-c608-95e748eeeb9e4ac756377c4fb2227b344b50226914e7554842981287d0d92be93
IEDL.DBID M48
ISSN 2168-8184
IngestDate Fri Nov 22 01:22:51 EST 2024
Thu Dec 12 02:23:05 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Keywords thrombocytosis
anti-ccp antibodies
rheumatoid arthriitis
disease activity score (das-28)
thrombocytopenia
ra factor
Language English
License Copyright © 2024, Butt et al.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c608-95e748eeeb9e4ac756377c4fb2227b344b50226914e7554842981287d0d92be93
PMID 39650908
ParticipantIDs crossref_primary_10_7759_cureus_73112
pubmed_primary_39650908
PublicationCentury 2000
PublicationDate 2024-11-6
PublicationDateYYYYMMDD 2024-11-06
PublicationDate_xml – month: 11
  year: 2024
  text: 2024-11-6
  day: 06
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Curēus (Palo Alto, CA)
PublicationTitleAlternate Cureus
PublicationYear 2024
References Hochberg MC (ref21) 2008; 24
Pathare SK (ref11) 2006; 45
Hutchinson RM (ref6) 1976; 35
Ayvaz OC (ref7) 2012; 32
Agashe RP (ref18) 2022; 21
Butt NI (ref24) 2023; 19
Bernatsky S (ref17) 2013; 42
Young A (ref26) 2007; 21
Honma T (ref22) 2024; 25
Ajmal M (ref4) 2022; 2022
Ichikawa N (ref13) 2001; 11
Kistangari G (ref12) 2013; 27
van Riel PL (ref15) 2016; 34
Jeon K (ref3) 2020; 99
Bowman SJ (ref10) 2002; 31
Roudier J (ref27) 2006; 8
Palta S (ref2) 2014; 58
Tripathi S (ref8) 2019; 2
Al-Ghamdi A (ref20) 2009; 29
Swinkels M (ref5) 2018; 9
Azam W (ref19) 2018; 34
Brière JB (ref16) 2007; 2
GBD 2021 Rheumatoid Arthritis Collaborators (ref25) 2023; 5
Bobircă A (ref1) 2022; 12
Vanni KM (ref9) 2020; 59
Kay J (ref14) 2012; 51 Suppl 6
Turesson C (ref23) 1999; 38
References_xml – volume: 99
  year: 2020
  ident: ref3
  article-title: Immature platelet fraction: a useful marker for identifying the cause of thrombocytopenia and predicting platelet recovery
  publication-title: Medicine (Baltimore)
  doi: 10.1097/MD.0000000000019096
  contributor:
    fullname: Jeon K
– volume: 2022
  year: 2022
  ident: ref4
  article-title: Thrombocytopenia and its comparison with Plasmodium vivax and Plasmodium falciparum in malaria patients
  publication-title: Pak J Med Res
  contributor:
    fullname: Ajmal M
– volume: 35
  year: 1976
  ident: ref6
  article-title: Thrombocytosis in rheumatoid arthritis
  publication-title: Ann Rheum Dis
  doi: 10.1136/ard.35.2.138
  contributor:
    fullname: Hutchinson RM
– volume: 59
  year: 2020
  ident: ref9
  article-title: Cytopenias among patients with rheumatic diseases using methotrexate: a meta-analysis of randomized controlled clinical trials
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kez343
  contributor:
    fullname: Vanni KM
– volume: 21
  year: 2022
  ident: ref18
  article-title: JAK: not just another kinase
  publication-title: Mol Cancer Ther
  doi: 10.1158/1535-7163.MCT-22-0323
  contributor:
    fullname: Agashe RP
– volume: 9
  year: 2018
  ident: ref5
  article-title: Emerging concepts in immune thrombocytopenia
  publication-title: Front Immunol
  doi: 10.3389/fimmu.2018.00880
  contributor:
    fullname: Swinkels M
– volume: 31
  year: 2002
  ident: ref10
  article-title: Hematological manifestations of rheumatoid arthritis
  publication-title: Scand J Rheumatol
  doi: 10.1080/030097402760375124
  contributor:
    fullname: Bowman SJ
– volume: 34
  year: 2018
  ident: ref19
  article-title: An elusive case of digital ischemia in a patient with rheumatoid arthritis
  publication-title: Pak J Med Sci
  doi: 10.12669/pjms.344.15281
  contributor:
    fullname: Azam W
– volume: 5
  year: 2023
  ident: ref25
  article-title: Global, regional, and national burden of rheumatoid arthritis, 1990-2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
  publication-title: Lancet Rheumatol
  doi: 10.1016/S2665-9913(23)00211-4
  contributor:
    fullname: GBD 2021 Rheumatoid Arthritis Collaborators
– volume: 25
  year: 2024
  ident: ref22
  article-title: Drug-drug interaction assessment based on a large-scale spontaneous reporting system for hepato- and renal-toxicity, and thrombocytopenia with concomitant low-dose methotrexate and analgesics use
  publication-title: BMC Pharmacol Toxicol
  doi: 10.1186/s40360-024-00738-6
  contributor:
    fullname: Honma T
– volume: 21
  year: 2007
  ident: ref26
  article-title: Extra-articular manifestations and complications of rheumatoid arthritis
  publication-title: Best Pract Res Clin Rheumatol
  doi: 10.1016/j.berh.2007.05.007
  contributor:
    fullname: Young A
– volume: 11
  year: 2001
  ident: ref13
  article-title: Immune thrombocytopenic purpura associated with rheumatoid arthritis - a report of five cases and review of the literature
  publication-title: Mod Rheumatol
  doi: 10.3109/s101650170013
  contributor:
    fullname: Ichikawa N
– volume: 32
  year: 2012
  ident: ref7
  article-title: Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia
  publication-title: Rheumatol Int
  doi: 10.1007/s00296-010-1747-0
  contributor:
    fullname: Ayvaz OC
– volume: 45
  year: 2006
  ident: ref11
  article-title: TNFalpha blocker-induced thrombocytopenia
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kel204
  contributor:
    fullname: Pathare SK
– volume: 27
  year: 2013
  ident: ref12
  article-title: Immune thrombocytopenia
  publication-title: Hematol Oncol Clin North Am
  doi: 10.1016/j.hoc.2013.03.001
  contributor:
    fullname: Kistangari G
– volume: 8
  year: 2006
  ident: ref27
  article-title: HLA-DRB1 genes and extraarticular rheumatoid arthritis
  publication-title: Arthritis Res Ther
  doi: 10.1186/ar1886
  contributor:
    fullname: Roudier J
– volume: 34
  year: 2016
  ident: ref15
  article-title: The Disease Activity Score (DAS) and the Disease Activity Score using 28 joint counts (DAS28) in the management of rheumatoid arthritis
  publication-title: Clin Exp Rheumatol
  contributor:
    fullname: van Riel PL
– volume: 2
  year: 2019
  ident: ref8
  article-title: Frequency of occurrence of haematological abnormalities among rheumatoid arthritis patients
  publication-title: Int J Clin Diagn Pathol
  doi: 10.33545/pathol.2019.v2.i2g.134
  contributor:
    fullname: Tripathi S
– volume: 24
  year: 2008
  ident: ref21
  article-title: The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006
  publication-title: Curr Med Res Opin
  doi: 10.1185/030079908x261177
  contributor:
    fullname: Hochberg MC
– volume: 42
  year: 2013
  ident: ref17
  article-title: Cancer risk in systemic lupus: an updated international multi-centre cohort study
  publication-title: J Autoimmun
  doi: 10.1016/j.jaut.2012.12.009
  contributor:
    fullname: Bernatsky S
– volume: 51 Suppl 6
  year: 2012
  ident: ref14
  article-title: ACR/EULAR 2010 rheumatoid arthritis classification criteria
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/kes279
  contributor:
    fullname: Kay J
– volume: 12
  year: 2022
  ident: ref1
  article-title: COVID-19-a trigger factor for severe immune-mediated thrombocytopenia in active rheumatoid arthritis
  publication-title: Life (Basel)
  doi: 10.3390/life12010077
  contributor:
    fullname: Bobircă A
– volume: 2
  year: 2007
  ident: ref16
  article-title: Essential thrombocythemia
  publication-title: Orphanet J Rare Dis
  doi: 10.1186/1750-1172-2-3
  contributor:
    fullname: Brière JB
– volume: 38
  year: 1999
  ident: ref23
  article-title: Extra-articular rheumatoid arthritis: prevalence and mortality
  publication-title: Rheumatology (Oxford)
  doi: 10.1093/rheumatology/38.7.668
  contributor:
    fullname: Turesson C
– volume: 19
  year: 2023
  ident: ref24
  article-title: Prevalence of carpal tunnel syndrome in patients with rheumatoid arthritis and its association with disease severity
  publication-title: Pak J Phsyiol
  doi: 10.69656/pjp.v19i4.1537
  contributor:
    fullname: Butt NI
– volume: 29
  year: 2009
  ident: ref20
  article-title: Extra-articular manifestations of rheumatoid arthritis: a hospital-based study
  publication-title: Ann Saudi Med
  doi: 10.4103/0256-4947.51774
  contributor:
    fullname: Al-Ghamdi A
– volume: 58
  year: 2014
  ident: ref2
  article-title: Overview of the coagulation system
  publication-title: Indian J Anaesth
  doi: 10.4103/0019-5049.144643
  contributor:
    fullname: Palta S
SSID ssj0001072070
Score 2.3243597
Snippet Background and objective This study aims to investigate thrombocytosis and thrombocytopenia in treatment-naïve rheumatoid arthritis (RA) patients, addressing...
SourceID crossref
pubmed
SourceType Aggregation Database
Index Database
StartPage e73112
Title Thrombocytosis and Thrombocytopenia in Treatment-Naïve Rheumatoid Arthritis Patients: A Single-Centre Retrospective Data-Based Study From Pakistan
URI https://www.ncbi.nlm.nih.gov/pubmed/39650908
Volume 16
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dSsMwFA6iIN6I_86fkQu9zOyaNGm9kU0dIjhEN9jdaNKMDWarbSfuOXwQH8IX8yRtxaEX3oZwAuek_b4k53wHoRNACMCFUUSagB-EKWoeCZVHOFVKUaUlj6zaZ5ff9NntwBssoarbaOnA7M-jnekn1U-njbeX-QV88MBfG0J4wZmapXqWNQRtmnbDKy5goknuuiuJvr1tcYTr2M5xbpP7BFCKFVnwvwws4NMC07SI09lA6yVVxK0itptoScdbaPWufAzfRu-9cZo8yUTN8ySbZDiMI_xj6Nmk0eFJjHtVLjnphp8frxo_jPUMiGoyiYzxsZU1wveFwGp2jlv4EfBsqom9-YXpOk-TqiITX4V5SNqAfRE2OYhz3IEVcUlE4x3U61z3Lm9I2WOBKO7Ar87TgvlaaxloFirhcSqEYiNpSmQlZUx6API8aDItgHj4gF7ACHwROVHgSh3QXbQcJ7HeRzj0qBRROFI-YxBzoBEho8Lo5XuwS1xeQ6eVY4fPhZLGEE4gJgDDIgBDG4Aa2iu8_j2LBkbmz_EP_mnhEK25QD1sxSA_Qst5OtPHQB1yWUcr7evu_UPd7o4vIEjGyQ
link.rule.ids 314,780,784,2221,24318,27924,27925
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Thrombocytosis+and+Thrombocytopenia+in+Treatment-Na%C3%AFve+Rheumatoid+Arthritis+Patients%3A+A+Single-Centre+Retrospective+Data-Based+Study+From+Pakistan&rft.jtitle=Cur%C4%93us+%28Palo+Alto%2C+CA%29&rft.au=Butt%2C+Nauman+Ismat&rft.au=Ghoauri%2C+Muhammad+Sohail+Ajmal&rft.au=Waris%2C+Barak&rft.au=Javed%2C+Muhammad+Umair&rft.date=2024-11-06&rft.issn=2168-8184&rft.eissn=2168-8184&rft_id=info:doi/10.7759%2Fcureus.73112&rft.externalDBID=n%2Fa&rft.externalDocID=10_7759_cureus_73112
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2168-8184&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2168-8184&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2168-8184&client=summon